Which statement is true about Type 2 antiarrhythmics?

Prepare for the INBDE Pharmacology Test with flashcards and multiple-choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which statement is true about Type 2 antiarrhythmics?

Explanation:
Beta-adrenergic blockade reduces sympathetic influence on the heart, especially at the SA node and AV node. By blocking beta-1 receptors, these drugs lower cAMP levels, decrease calcium influx in nodal tissue, and slow the slope of phase 4 and AV conduction. The result is a slower heart rate and a slower ventricular response, which helps control supraventricular tachyarrhythmias. This mechanism distinguishes them from drugs that block specific ion channels: Na+ channel blockers affect conduction in other ways (Class I), K+ channel blockers affect repolarization (Class III), and Ca2+ channel blockers (Class IV) act directly on calcium influx. Clinically, they are used to blunt sympathetic stimulation and control rate in tachyarrhythmias, with examples like propranolol, metoprolol, and esmolol.

Beta-adrenergic blockade reduces sympathetic influence on the heart, especially at the SA node and AV node. By blocking beta-1 receptors, these drugs lower cAMP levels, decrease calcium influx in nodal tissue, and slow the slope of phase 4 and AV conduction. The result is a slower heart rate and a slower ventricular response, which helps control supraventricular tachyarrhythmias. This mechanism distinguishes them from drugs that block specific ion channels: Na+ channel blockers affect conduction in other ways (Class I), K+ channel blockers affect repolarization (Class III), and Ca2+ channel blockers (Class IV) act directly on calcium influx. Clinically, they are used to blunt sympathetic stimulation and control rate in tachyarrhythmias, with examples like propranolol, metoprolol, and esmolol.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy